ClinicalTrials.gg
Drug

Viloxazine clinical trials

Also written SPN-812.

studies test it
13
open now
1
in phase 3
8
first study started
2016

How each study uses Viloxazine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Viloxazine studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
2 Apr 2021 · QELBREE · NDA 211964 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

200mg SPN-812
4
400mg SPN-812
4
viloxazine extended-release capsules
3
100mg SPN-812
3

Brand

Qelbree
1

Development codes

SPN-812
10

Studies by the year they started

13 studies that test it; most in 2017 (4)

Studies that test Viloxazine, by start year
YearStudies
20162
20174
20192
20201
20211
20231
20242

By phase

A phase 1/2 study counts in both.

Phase 2
1
Phase 3
8
Phase 4
4

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 13 · Other 0

Supernus Pharmaceuticals, Inc. (13)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1, 1 in phase 3

Studies that test Viloxazine, phase 3 first.

Studies

Open first, then newest update. How each study uses Viloxazine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 13

Codes

What other systems call Viloxazine · ClinicalTrials.gg INT008406

  • MeSH (NLM) D014745ViloxazineConfirmed NLM, Wikidata
  • UNII (FDA) 5I5Y2789ZFVILOXAZINEConfirmed FDA, NLM, Wikidata
  • RxNorm 11196Confirmed FDA, Wikidata
  • Wikidata Q907148viloxazineConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C152877ViloxazineOne source FDA
  • DrugBank DB09185One source Wikidata

Also registered as viloxazine hydrochloride (UNII OQW30I1332 · RxNorm 142143).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.